3
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Production Layer Salmonella Enteritidis Control through Dry Fed Pre & Probiotic Products

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          ABSTRACT Increasing interest in multiple strain Bacillus probiotics and parietal yeast fractions as feed ingredients for egg laying hen diets has also led to food safety questions. This study was undertaken to evaluate the ability of these products to reduce Salmonella Enteritidis colonization. Sixty Hy-Line hens aged 56 weeks were placed in individual cages and fed a mash diet containing one of the following treatments, control, Bacillus spp. probiotic, yeast cell wall, or a combination of yeast cell wall and Bacillus probiotic. At 60 weeks of age all hens were challenged orally with 7 x 107 CFU/bird of Salmonella Enteritidis. At 61 weeks of age, birds were humanely euthanized, by cervical dislocation and the ceca aseptically removed and cultured for S. Enteritidis prevalence and number by the Most Probable Number method. There was no significant difference in prevalence of Salmonella Enteritidis between the control and any treatments. The control birds had 4.37 log10 MPN/g of S. Enteritidis detected in the ceca. The Probiotic group had 2.96 MPN/g, a reduction of 1.41(p<0.05) and the yeast cell wall group had 2.89 MPN/g a reduction of 1.48 (p<0.05). The combination had 3.60 MPN/g a numerical reduction of 0.78 (p=0.14). The yeast cell wall and Bacillus probiotic groups significantly reduced the amount of Salmonella Enteritidis in the ceca of the laying hens.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          The global burden of nontyphoidal Salmonella gastroenteritis.

          To estimate the global burden of nontyphoidal Salmonella gastroenteritis, we synthesized existing data from laboratory-based surveillance and special studies, with a hierarchical preference to (1) prospective population-based studies, (2) "multiplier studies," (3) disease notifications, (4) returning traveler data, and (5) extrapolation. We applied incidence estimates to population projections for the 21 Global Burden of Disease regions to calculate regional numbers of cases, which were summed to provide a global number of cases. Uncertainty calculations were performed using Monte Carlo simulation. We estimated that 93.8 million cases (5th to 95th percentile, 61.8-131.6 million) of gastroenteritis due to Salmonella species occur globally each year, with 155,000 deaths (5th to 95th percentile, 39,000-303,000 deaths). Of these, we estimated 80.3 million cases were foodborne. Salmonella infection represents a considerable burden in both developing and developed countries. Efforts to reduce transmission of salmonellae by food and other routes must be implemented on a global scale.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection.

            Bifidobacteria comprise a significant proportion of the human gut microbiota. Several bifidobacterial strains are currently used as therapeutic interventions, claiming various health benefits by acting as probiotics. However, the precise mechanisms by which they maintain habitation within their host and consequently provide these benefits are not fully understood. Here we show that Bifidobacterium breve UCC2003 produces a cell surface-associated exopolysaccharide (EPS), the biosynthesis of which is directed by either half of a bidirectional gene cluster, thus leading to production of one of two possible EPSs. Alternate transcription of the two opposing halves of this cluster appears to be the result of promoter reorientation. Surface EPS provided stress tolerance and promoted in vivo persistence, but not initial colonization. Marked differences were observed in host immune response: strains producing surface EPS (EPS(+)) failed to elicit a strong immune response compared with EPS-deficient variants. Specifically, EPS production was shown to be linked to the evasion of adaptive B-cell responses. Furthermore, presence of EPS(+) B. breve reduced colonization levels of the gut pathogen Citrobacter rodentium. Our data thus assigns a pivotal and beneficial role for EPS in modulating various aspects of bifidobacterial-host interaction, including the ability of commensal bacteria to remain immunologically silent and in turn provide pathogen protection. This finding enforces the probiotic concept and provides mechanistic insights into health-promoting benefits for both animal and human hosts.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Antimicrobial and Probiotic Properties of Yeasts: From Fundamental to Novel Applications

              The yeasts constitute a large and heterogeneous group of microorganisms that are currently attracting increased attention from scientists and industry. Numerous and diverse biological activities make them promising candidates for a wide range of applications not limited to the food sector. In addition to their major contribution to flavor development in fermented foods, their antagonistic activities toward undesirable bacteria, and fungi are now widely known. These activities are associated with their competitiveness for nutrients, acidification of their growth medium, their tolerance of high concentrations of ethanol, and release of antimicrobial compounds such as antifungal killer toxins or “mycocins” and antibacterial compounds. While the design of foods containing probiotics (microorganisms that confer health benefits) has focused primarily on Lactobacillus and Bifidobacterium, the yeast Saccharomyces cerevisiae var. boulardii has long been known effective for treating gastroenteritis. In this review, the antimicrobial activities of yeasts are examined. Mechanisms underlying this antagonistic activity as well as recent applications of these biologically active yeasts in both the medical and veterinary sectors are described.
                Bookmark

                Author and article information

                Journal
                rbca
                Brazilian Journal of Poultry Science
                Braz. J. Poult. Sci.
                Fundação APINCO de Ciência e Tecnologia Avícolas (Campinas, SP, Brazil )
                1516-635X
                1806-9061
                2021
                : 23
                : 2
                : eRBCA-2020-1418
                Affiliations
                [4] Auburn AL orgnameAuburn University USA
                [1] Milwaukee WI orgnamePhileo by Lesaffre USA
                [2] Clemson South Carolina orgnameClemson University United States
                [3] Dallas TX orgnameGaydos Technical Services USA
                [5] TX orgnameTexas A&M University USA
                Article
                S1516-635X2021000200307 S1516-635X(21)02300200307
                10.1590/1806-9061-2020-1418
                5ca99d7d-9f08-4846-a879-31184e60858d

                This work is licensed under a Creative Commons Attribution 4.0 International License.

                History
                : 11 November 2020
                : 28 January 2021
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 34, Pages: 0
                Product

                SciELO Brazil

                Categories
                Original Articles

                Bacillus,laying hens,Salmonella Enteritidis,probiotic,yeast cell wall

                Comments

                Comment on this article